Literature DB >> 10369560

Terminally differentiated human neurons survive and integrate following transplantation into the traumatically injured rat brain.

J K Muir1, R Raghupathi, K E Saatman, C A Wilson, V M Lee, J Q Trojanowski, M F Philips, T K McIntosh.   

Abstract

The present study evaluated the survival and integration of human postmitotic neurons (hNT) following transplantation into the traumatically injured rodent brain. Anesthetized male Sprague-Dawley rats (n = 47) were subjected to lateral fluid percussion brain injury of moderate severity (2.4-2.6 atm). Sham animals (n = 28) were surgically prepared, but did not receive brain injury. At 24 h following injury or sham surgery, the rats were re-anesthetized and approximately 100,000 hNT cells (freshly cultured or previously frozen) or vehicle were stereotactically injected into the ipsilateral cortex. Animals were examined for neuromotor function at 48 h, 7 days, and 14 days posttransplantation using a standard battery of motor tests. Animals were sacrificed at 2 weeks postinjury and viability of hNT grafts was assessed by Nissl staining and MOC-1 immunohistochemistry, which recognizes human neural cell adhesion molecules (NCAM) expressed on hNT cells. Transplanted hNT grafts remained viable in 83% of brain-injured animals at 2 weeks following transplantation of either fresh or frozen hNT cells. Glial fibrillary acidic protein (GFAP) immunohistochemistry revealed a marked increase in the number of reactive astrocytes following brain injury in both vehicle and hNT implanted animals. These reactive astrocytes appeared not to impede grafted cells from sending projections into host tissue. Despite the survival of transplanted cells in the traumatically injured brain, hNT cells had no significant effect on posttraumatic neurologic motor function during the acute posttraumatic period. Since hNT cells are transfectable, prolonged survival of these transplanted cells in the posttraumatic milieu suggests that grafted hNT cells may be a suitable means for delivery of therapeutic, exogenous proteins into the CNS for treatment of traumatic brain injury.

Entities:  

Mesh:

Year:  1999        PMID: 10369560     DOI: 10.1089/neu.1999.16.403

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

Review 1.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

3.  Transplantation of GABAergic neurons but not astrocytes induces recovery of sensorimotor function in the traumatically injured brain.

Authors:  G D Becerra; L M Tatko; E S Pak; A K Murashov; M R Hoane
Journal:  Behav Brain Res       Date:  2007-02-01       Impact factor: 3.332

Review 4.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

5.  Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord.

Authors:  Gábor Márton; Dóra Tombácz; Judit S Tóth; András Szabó; Zsolt Boldogköi; Adám Dénes; Akos Hornyák; Antal Nógrádi
Journal:  BMC Neurosci       Date:  2010-05-29       Impact factor: 3.288

6.  Novel cellular approaches to repair of neurodegenerative disease: from Sertoli cells to umbilical cord blood stem cells.

Authors:  Paul R Sanberg; Alison E Willing; David W Cahill
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

7.  Comparative effect of immature neuronal or glial cell transplantation on motor functional recovery following experimental traumatic brain injury in rats.

Authors:  Fu-Shi Quan; Jian Chen; Yuan Zhong; Wen-Zhi Ren
Journal:  Exp Ther Med       Date:  2016-07-15       Impact factor: 2.447

Review 8.  Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury.

Authors:  Alison E Willing; Mahasweta Das; Mark Howell; Shyam S Mohapatra; Subhra Mohapatra
Journal:  CNS Neurosci Ther       Date:  2020-03-10       Impact factor: 5.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.